Ambu A/S' (CPH:AMBU B) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Most readers would already be aware that Ambu's (CPH:AMBU B) stock increased significantly by 13% over the past three months. However, we wonder if the company's inconsistent financials would have any adverse impact on the current share price momentum. Particularly, we will be paying attention to Ambu's ROE today.

Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.

Advertisement

How To Calculate Return On Equity?

Return on equity can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Ambu is:

5.6% = kr.326m ÷ kr.5.8b (Based on the trailing twelve months to December 2024).

The 'return' refers to a company's earnings over the last year. Another way to think of that is that for every DKK1 worth of equity, the company was able to earn DKK0.06 in profit.

See our latest analysis for Ambu

What Is The Relationship Between ROE And Earnings Growth?

Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company’s earnings growth potential. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.

Ambu's Earnings Growth And 5.6% ROE

When you first look at it, Ambu's ROE doesn't look that attractive. A quick further study shows that the company's ROE doesn't compare favorably to the industry average of 9.3% either. Therefore, Ambu's flat earnings over the past five years can possibly be explained by the low ROE amongst other factors.

As a next step, we compared Ambu's net income growth with the industry and discovered that the industry saw an average growth of 10% in the same period.

past-earnings-growth
CPSE:AMBU B Past Earnings Growth April 1st 2025

The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. Has the market priced in the future outlook for AMBU B? You can find out in our latest intrinsic value infographic research report.

Is Ambu Using Its Retained Earnings Effectively?

Despite having a normal three-year median payout ratio of 33% (implying that the company keeps 67% of its income) over the last three years, Ambu has seen a negligible amount of growth in earnings as we saw above. So there could be some other explanation in that regard. For instance, the company's business may be deteriorating.

Moreover, Ambu has been paying dividends for at least ten years or more suggesting that management must have perceived that the shareholders prefer dividends over earnings growth. Existing analyst estimates suggest that the company's future payout ratio is expected to drop to 21% over the next three years. As a result, the expected drop in Ambu's payout ratio explains the anticipated rise in the company's future ROE to 14%, over the same period.

Summary

In total, we're a bit ambivalent about Ambu's performance. While the company does have a high rate of reinvestment, the low ROE means that all that reinvestment is not reaping any benefit to its investors, and moreover, its having a negative impact on the earnings growth. With that said, we studied the latest analyst forecasts and found that while the company has shrunk its earnings in the past, analysts expect its earnings to grow in the future. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About CPSE:AMBU B

Ambu

Researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally.

Flawless balance sheet with solid track record.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0776.3% undervalued
83 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
YA
SOFI logo
Yang_ on SoFi Technologies ·

SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Fair Value:US$22.9820.4% undervalued
9 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
KO
CSL logo
Kouj on CSL ·

CSL: The Dip Is the Opportunity

Fair Value:AU$1556.7% undervalued
6 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
GA
DHT logo
GavrielH on DHT Holdings ·

DHT Holdings, inc: Strait of Hormuz Risk Amidst US-Israel vs Iran Tensions Spikes VLCC Rates.

Fair Value:US$3648.3% undervalued
2 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

AS
BFIT logo
ashwin3407 on Basic-Fit ·

Basic-Fit: Why the Market Is Mispricing Europe’s Largest Low-Cost Gym Operator

Fair Value:€68.4756.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CF
CFFF
DRO logo
CFFF on DroneShield ·

DroneShield's Growth Will Drive Revenue Up by 25.39% Amidst New Success

Fair Value:AU$1.36195.6% overvalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
PATH logo
Vestra on UiPath ·

UiPath Inc. (PATH): Agentic AI Pivot and Milestone Profits Set the Stage for Q4 Results

Fair Value:US$19.6841.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.376.9% undervalued
51 users have followed this narrative
3 users have commented on this narrative
27 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59631.9% undervalued
1306 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0227.0% undervalued
1102 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative